Last Call for canSERV Third Open Call Funding
Ein Dokument
mehr
Storys zum Thema Krebs
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Launch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"
Ein DokumentmehrLaunch of canSERV Call for Service Provision, "Training the Next Generation of Cancer Researchers"
Ein Dokumentmehr- 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr canSERV relaunches Open Call for Service Provision
Ein DokumentmehrcanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision Open
2 DokumentemehrPress release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
Ein DokumentmehrPress release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...
Ein DokumentmehrcanSERV invites applications for "Revolutionising Cancer Patient Care"
Ein Dokumentmehr- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
Ein Dokumentmehr LAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision
Ein Dokumentmehr- 3
canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer Research
Ein Dokumentmehr Leipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
Ein DokumentmehrStrengthening the Direct Sales and Service System for Business Expansion in Italy
Ein Dokumentmehr- 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
Ein Dokumentmehr canSERV Releases Open Call for Transnational Service Provision
Ein DokumentmehrFree Access to Cancer Research Services - canSERV 1st Call for Proposals
Ein Dokumentmehr- 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
Ein Dokumentmehr - 2
Lindis Biotech develops immunotherapy against bladder cancer
Ein Dokumentmehr - 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
Ein Dokumentmehr The development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB
Ein Dokumentmehr
1